Antibody fragments of predetermined binding specificity have recently
been constructed from repertoires of antibody V genes, bypassing hybri
doma technology and even immunization. The V gene repertoires are harv
ested from populations of lymphocytes, or assembled in vitro, and clon
ed for display of associated heavy and light chain variable domains on
the surface of filamentous bacteriophage. Rare phage are selected fro
m the repertoire by binding to antigen; soluble antibody fragments are
expressed from infected bacteria; and the affinity of binding of sele
cted antibodies is improved by mutation. The process mimics immune sel
ection, and antibodies with many different binding specificities have
been isolated from the same phage repertoire. Thus human antibody frag
ments have been isolated with specificities against both foreign and s
elf antigens, including haptens, carbohydrates, secreted and cell surf
ace proteins, viral coat proteins, and intracellular antigens from the
lumen of the endoplasmic reticulum and the nucleus. Such antibodies h
ave potential as reagents for research and in therapy.